biotech

FDA Approves MedImmune's UK Influenza Vaccine Manufacturing Facility

Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics on January 3, 2006

BlogPicture

Medimmune announced last week that the US FDA has approved its newly constructed influenza vaccine manufacturing facility in England, enabling them to to produce up to 15 million bulk doses per month, or approximately 90 million bulk doses per influenza manufacturing season, of its trivalent, intranasal influenza vaccine, FluMist (Influenza Virus Vaccine Live, Attenuated).

Additionally, the plant will be used to manufacture its investigational flu vaccine, CAIV-T, as well as year-round vaccine production in case of a flu pandemic.

Source: MedImmune

Permalink: FDA Approves MedImmune's UK Influenza Vaccine Manufacturing Facility

Tags: flu  vaccine  biotech  influenza  manufacturing  influenza+vaccine  vaccine+manufacturing  manufacturing+fa 

Vote for FDA Approves MedImmune's UK Influenza Vaccine Manufacturing Facility:

  • Currently 7.50/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 7.50 out of 4 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Tagcloud
Most Popular   Best of   Biotech Hubs and Facilities   Biotech/Science Blogs   Corporate and Industrial News   Diagnostics, Methodologies and Instrumentation   Did you know   Drugs, Vaccines and Therapeutics   Energy, Environment and Ecology   Food and Agriculture   Gene Therapy   Genomics, Proteomics and Bioinformatics   Information About   Meetings and Other Events   Microbiology   Misc   Nanomedicine   Other Biotechnology News   Patents and Intellectual Property Rights   Quick introduction   Stem Cells